Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05291715
Other study ID # 131221
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 15, 2022
Est. completion date December 25, 2022

Study information

Verified date February 2023
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Gaseous ozone (O3-triatomic oxygen) is the third-strongest oxidizing agent worldwide. It influences the cellular and the humoral immune system, by stimulating the proliferation of immunocompetent cells and the synthesis of immunoglobulin. Additionally; biologically active substances, such as interleukins, leukotrienes and prostaglandins which are beneficial in reducing inflammation and wound healing are orchestrated following ozone application. Given that after harvesting of a free gingival graft from the palatal donor site, healing occurs by secondary intention process; for patients with mucogingival conditions. The investigators will compare the natural process of healing at the donor site versus the healing process consecutive to ozone application; with the primary outcome is to evaluate the postoperative pain perception using visual analogue scale and to estimate the consumption of analgesics tablets after surgery.


Description:

The procedures will be explained to all participants and they will be asked to sign an informed consent. All patients will receive oral hygiene instructions and will receive phase I therapy comprising supragingival scaling and subgingival debridement. After completion of phase I therapy the patients will be re-examined to ensure meeting all inclusion criteria. Then the participants will be allocated to 2 groups. Group I will receive ozone therapy after harvesting free gingival graft. Group II following the harvesting of the free gingival graft, will be protected by a periodontal pack. Surgical intervention: Graft harvesting at donor site (Sullivan, & Atkins, 1968) To prepare the donor area, a rectangular-shape incision with 1-1.5 mm thickness will be made, and care will be taken to place most of the coronal part of the incision at least 2 mm apical from gingival margins of the upper teeth. The apical coronal dimension of the graft. Following administration of anaesthesia by local infiltration (2% lidocaine with 1:100,000 epinephrine), a template will be placed over the palatal mucosa and will be used to outline the dimensions of the graft. The area chosen to harvest the free gingival graft will be chosen between first premolar and first molar. The outlined graft will be carefully harvested as follows: The surgical blade entered in the contour incision, always in the posterior limit, sliding below the mucosa, and continued to find the opposite contour incision, in the anterior limit. The connective tissue surface will be carefully inspected for irregularities or adipose tissue after graft separation. Graft thickness will be immediately prepared (thinned) to obtain a graft approximately 1 to 1.5 mm thick. The palatal wound will be protected by a periodontal pack; for the control group. While the test group, will receive ozone therapy. Ozone Application Protocol: An ozone generator device (Ozone DTA-APOZAa- enterPrize Co9-Taiwan,R.0,C) with different probe numbers (#1 pointed probe,#2 pointed probe and #3 flat probe) will be used according to the manufacturer's instructions. Ozone will be applied on donor sites immediately after surgery and at days 1, 3, 7, 14 post-surgeries in the test group with output power at level 6-12 for 1 minute. Ozone application in the control group will be simulated without starting the ozone generator. Postoperative Protocol: The participants will be instructed to abstain from brushing and flossing the teeth at the surgical area until suture removal (7days) and to use an antimicrobial rinse (0.12% chlorhexidine, 15 ml for 60 seconds twice daily) solution two times a day for 4 weeks. The participants will be also instructed to consume only soft foods during the first week and to avoid any other mechanical trauma to the treated sites. The participants will be given a prescription of Ibuprofen (600 mg every 12 hours) to be taken if necessary and the participants will be asked to record the number of tablets taken. Participants will be enrolled in a professional plaque control program weekly for the first 4 weeks, then monthly until the end of the study.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date December 25, 2022
Est. primary completion date December 15, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Patients with mucogingival defects to be treated with free gingival grafts. - Age older than 18 years old. - No history of periodontal surgery in the area to be treated. - Full mouth plaque score (FMPS) and full mouth bleeding score (FMBS) less than 20%. Exclusion Criteria: - Smoking - Pregnancy and lactation. - History of systematic diseases or medications that interferes with periodontal wound healing.

Study Design


Intervention

Device:
Ozone generator device (Ozone DTA-APOZAa-enterprize CO9-Taiwan, R.0.C)
Gaseous ozone ( O3-triatomic oxygen) activates the neuroprotective systems, improve the blood circulation, oxygen delivery, stimulate the immunocompetent cells and enhance the release of growth factors. Moreover, ozone therapy showed to increase the quality of life post-operatively to a free gingival graft harvesting and decrease post-operative pain sensation ( Tasdemir et al, 2016)

Locations

Country Name City State
Egypt Cairo University-Faculty of Dentistry Cairo Manial, Giza

Sponsors (1)

Lead Sponsor Collaborator
Omaima Mossad Mahmoud AL-Sherbini

Country where clinical trial is conducted

Egypt, 

References & Publications (2)

Miller PD Jr. Root coverage using the free soft tissue autograft following citric acid application. III. A successful and predictable procedure in areas of deep-wide recession. Int J Periodontics Restorative Dent. 1985;5(2):14-37. No abstract available. — View Citation

Ozcan M, Ucak O, Alkaya B, Keceli S, Seydaoglu G, Haytac MC. Effects of Platelet-Rich Fibrin on Palatal Wound Healing After Free Gingival Graft Harvesting: A Comparative Randomized Controlled Clinical Trial. Int J Periodontics Restorative Dent. 2017 Sep/Oct;37(5):e270-e278. doi: 10.11607/prd.3226. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Evaluation of postoperative pain using visual analog scale. Postoperative pain will be evaluated by visual analog scale (VAS) (Crichton, 2001).
In this method, the patients will be asked to rate their pain at examination in form of a score between 0 (no pain) and 10 (the most pain which patient has ever experienced).
This assessment will be made every day for the first 7 days following the FGG operation.
7 days
Primary Evaluation of postoperative pain The participants will report the number of analgesic tablets ingested to relieve the pain. 7 days
Secondary Evaluation of complete epithelialization of the palatal wound. Hydrogen peroxide test (H 2 O 2) for assessment of epithelialization in control and test groups and at days 7, 14, 21 and 28, a 3% H 2 O 2 will be sprinkled on the palatal wounds by using a syringe. If the epithelium is discontinuous, it diffuses into the connective tissue, and the enzyme catalase acts on H 2 O 2 to release water and oxygen showing bubbles on the wound of FGG. Complete epithelialization will be scored clinically, following visual inspection (Yes, no). If the epithelial barrier is intact, then H2O2 does not diffuse into the connective tissue, it is not acted upon by catalase, and oxygen is not liberated. Absence of bubble formation following hydrogen peroxide application will be scored as positive complete epithelialization (Silva et al.,2010). 28 days
See also
  Status Clinical Trial Phase
Completed NCT05480111 - The Role of Quadratus Lumborum Blocks Following Minimally Invasive Hysterectomy Phase 4
Completed NCT06129305 - Erector Spina Muscle Distance From the Skin at Different Thoracal Elevations
Completed NCT04401826 - Micro-surgical Treatment of Gummy Smile N/A
Recruiting NCT04020133 - the Role of Popliteal Plexus Block in Pain Management After Anterior Cruciate Ligament Reconstruction. N/A
Completed NCT03023462 - Efficacy of an Anterior Quadratus Lumborum Block vs. a TAP-block for Inguinal Hernia Repair N/A
Completed NCT03546738 - Spinal Cord Burst Stimulation for Chronic Radicular Pain Following Lumbar Spine Surgery N/A
Completed NCT03652103 - Efficiency of Erector Spinae Plane Block For Patients Undergoing Percutaneous Nephrolithotomy Phase 4
Withdrawn NCT03528343 - Narcotic vs. Non-narcotic Pain Regimens After Pediatric Appendectomy Phase 1/Phase 2
Terminated NCT03261193 - ITM + Bupivacaine QLB vs. ITM + Sham Saline QLB for Cesarean Delivery Pain Phase 3
Completed NCT02525133 - Phase 3 Study of Efficacy and Safety of the XaraColl® Bupivacaine Implant After Hernioplasty Phase 3
Completed NCT03244540 - Regional Analgesia After Cesarean Section Phase 4
Enrolling by invitation NCT05316168 - Post Operative Pain Management for ACL Reconstruction Phase 3
Recruiting NCT04130464 - Intraperitoneal Infusion of Analgesic for Postoperative Pain Management Phase 4
Enrolling by invitation NCT04574791 - Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty N/A
Completed NCT04526236 - Influence of Aging on Perioperative Methadone Dosing Phase 4
Completed NCT04073069 - Scalp Infiltration With Diprospan Plus Ropivacaine for Postoperative Pain After Craniotomy in Adults Phase 4
Recruiting NCT05351229 - Intrathecal Morphine for Analgesia in Video-assisted Thoracic Surgery Phase 4
Enrolling by invitation NCT05543109 - Ultrasound Guided Psoas Compartment Block vs Suprainguinal Fascia Iliaca Compartment Block N/A
Completed NCT05346588 - THRIVE Feasibility Trial Phase 3
Completed NCT04919317 - Combination Dexamethasone and Bupivacaine Pain Control in Reduction Mammaplasty Phase 2